Instructions for authors
The instructions for authors include information about the types of articles received for publication, preparing a manuscript for submission to the Southern African Journal of HIV Medicine and the online submission process. Other relevant information about the journal's policies and the reviewing process can be found under the about section.
- Frequently asked questions from authors
- Types of articles published by the Southern African Journal of HIV Medicine
- Publication procedure
- Publication fees
- Copyright and licensing
- Legal document
- Authorship and competing interest
- Human and Animal Rights
Proceed to submit:
- New submission
- Revised submission (after formal peer review)
- Thesis abstract (create awareness for your research)
Types of articles published by the Southern African Journal of HIV Medicine↑
Most articles published by the Southern African Journal of HIV Medicine follow a specific format, as listed below:
- Original research articles: feature original research, theory, and/or best practice related to HIV/AIDS treatment, prevention and related topics relevant to clinical and public health practice (approx. 3500 - 5500 words). Compulsory as a supplementary file: Ethical clearance letter/certificate.
- Case reports: documented diagnosis and treatment of a patient, or a potential description of the implementation of an educational programme or healthcare-related intervention towards the improvement of human development (between 500 and 800 words). Compulsory as a supplementary file: Ethical clearance letter/certificate.
References: Begin the reference list on a separate page. The Southern African Journal of HIV Medicine uses the Vancouver referencing style. Note: no other style will be permitted.
Learn how to ensure your manuscript adheres to the AOSIS Publishing house style.
The submission process can be interrupted at any time; when users return to their journal’s personalised section, they can continue from where they left off.
Publication procedure ↑
On the acceptance of a manuscript for publication by the Editor-in-Chief, the editorial staff will work towards preparing the manuscript for online publication.
The first stage is the language editing that is returned to the corresponding author for review. This will be the final opportunity for the author to make text changes to the manuscript. At a later stage, the editorial staff will send the author one set of galley proofs, at which time the author will have two working days to mark any typographical errors. It may not be possible to incorporate author corrections in the printed version of the manuscript in the event of the author failing to respond to the proofreading requests. Authors should visit their personalised home page frequently to assess the location or stage of the manuscript.
Publication fees ↑
Article Processing Charges (APC)
The journal is funded by the Southern African HIV Clinicians Society. Until further notice no APC will be charged to publish in the journal. The average length of an article in this journal is 6 pages.
Article Submission Charges (ASC)
ASC does not apply.
Text changes after layout
Authors will be given the opportunity to revise and approve the text of the accepted manuscript in the final phase of copy-editing. After author approval the manuscript will go to design layout. The author will be asked to proofread the final galleys before going to publishing. Proofreading is intended to correct typesetting mistakes and not to introduce new changes to the text; such changes will require new layout of the pages. If new changes are introduced at this final proofreading stage, the publisher will charge a Galley Change Fee (GCF) to the author, based on the cost incurred to make such changes.
The GCF for this journal is R450.00 [excluding VAT] per hour.
Invoicing (if applicable)
Only one invoice shall be issued per article (no splitting of invoices) in order to expedite publication and keep costs to a minimum. All amounts are due within 30 days from invoicing. Payment can be made by Credit Card and Electronic Funds Transfer (EFT). The article will only be published once full payment has been received. If payment is done by EFT from a non-South African bank account, the author will be responsible for any bank transfer charges at the time of the transaction. In all cases a receipt will be sent by email once payment has been received. Learn how to make a payment.
Funding body agreements
Waiver of APC & ASC
No waiver applies since no APCs or ASCs apply.
Publication fee policy
The journal adheres to our publication fee policy, which includes our reimbursement policy.
The author(s) retain copyright on work published by AOSIS unless specified otherwise.
Licensing and publishing rights
Author(s) of work published by AOSIS are required to grant AOSIS the unlimited rights to publish the definitive work in any format, language and medium, for any lawful purpose. AOSIS requires journal authors to publish their work in open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
Read more here: http://creativecommons.org/licenses/by/4.0/.
The authors retain the non-exclusive right to do anything they wish with the published article(s), provided attribution is given to the applicable journal with details of the original publication, as set out in the official citation of the article published in the journal. The retained right specifically includes the right to post the article on the authors’ or their institution’s websites or in institutional repositories.
Previously published work may have been published under a different licence. We advise the community that if they would like to reuse the work to consult the applicable licence at article level.
Legal document ↑
The following legal document need to be submitted with the manuscript to the journal online; please download below:
Where a manuscript is not accepted for publication by the Editor-in-Chief, the sections of the publication agreement in respect of the publishing licensing shall be null and void and the authors will be free to submit the manuscript to any other publication for first publication.
Authorship and competing interest ↑All co-authors (collaborators) share a degree of responsibility for articles they collaborate on. Hence, if an individual is unwilling to accept appropriate responsibility for a manuscript’s contents, the individual should not be a co-author.
A ‘co-author’ is defined as any person who has made a significant scientific contribution to the work reported and who shares responsibility and accountability for the results. We advise that authorship credit should follow and be based on:
- substantial contributions to conception and design, acquisition of data or analysis and interpretation of data
- drafting the article or revising it critically for important intellectual content
- final approval of the version to be published.
J.K. (University of Pretoria) was the project leader, L.M.N. (University of KwaZulu-Natal) and A.B. (Stellenbosch University) were responsible for experimental and project design. L.M.N. performed most of the experiments. P.R. (Cape Peninsula University of Technology) made conceptual contributions and S.T. (University of Cape Town), U.V. (University of Cape Town) and C.D. (University of Cape Town) performed some of the experiments. S.M. (Cape Peninsula University of Technology) and V.C. (Cape Peninsula University of Technology) prepared the samples and calculations were performed by C.S.(Cape Peninsula University of Technology).
AOSIS will seek reasons for any requests for changes in authorship; ensure changes are legitimate, justified and authorised by all authors.
Competing interest exist when an author’s interpretation of data or presentation of information may be influenced by a personal or financial relationship with other people or organisations that can potentially prevent the authors from executing and publishing unbiased research. Authors should disclose any financial competing interests as well as any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.
Where an author gives no competing interests, the listing will read ‘The authors declare that they have no financial or personal relationship(s) that may have inappropriately influenced them in writing this article.’
All research involving human participants must have been approved by the authors' institutional review board or equivalent committee(s). This board must be named by the authors in the manuscript. For research involving human participants, informed consent must have been obtained (or the reason for lack of consent explained, e.g. the data were analysed anonymously) and all clinical investigation must have been conducted according to the principles expressed in the Declaration of Helsinki on 'Ethical Principles for Medical Research Involving Human Subjects'. Authors should submit a statement from their ethics committee or institutional review board indicating the approval of the research. We also encourage authors to submit a sample of a patient consent form and may require submission of completed forms on particular occasions. Case studies also requires the consent of the patient(s) or waiver of consent approved by an ethics committee, and permission has been declared and submitted to the editor at the time of submission.
For studies involving humans categorised by race/ethnicity, age, disease/disabilities, religion, sex/gender, sexual orientation, or other socially constructed groupings, authors should, as much as possible:
- make explicit their methods of categorising human populations;
- define categories in as much detail as the study protocol allows;
- justify their choices of definitions and categories, including for example whether any rules of human categorisation were required by their funding agency;
- explain whether (and if so, how) they controlled for confounding variables such as socio-economic status, nutrition, environmental exposures, etc.
In addition, outmoded terms and potentially stigmatising labels should be changed to more current, acceptable terminology. Examples: 'Caucasian' should be changed to 'white' or 'of [Western] European descent' (as appropriate); 'cancer victims' should be changed to 'people with cancer'.
All animal work must have been conducted according to relevant national and international guidelines. We specifically require authors to include details of animal welfare and steps taken to ameliorate suffering in all work involving non-human primates. Manuscripts describing research involving non–human primates should also indicate that the ARRIVE guidelines for reporting in vivo animal experiments were adhered to.
|ISSN: 1608-9693 (print) | ISSN: 2078-6751 (online)|
Subscribe to our newsletter
All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.
Website design & content: ©2017 AOSIS (Pty) Ltd. All rights reserved. No unauthorised duplication allowed.
AOSIS Publishing | Empowering Africa through access to knowledge
publishing(AT)aosis.co.za replace (AT) with @Please read the privacy statement.